OC
APYX icon

Oppenheimer & Co’s Apyx Medical APYX Stock Holding History

Oppenheimer & Co’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,400
Closed -$17K – 1273
2016
Q2 		$17K Sell
10,400
-3,400
-25% -$5.9K ﹤0.01% 1210
2016
Q1 		$23K Sell
13,800
-100
-0.7% -$201 ﹤0.01% 1226
2015
Q4 		$29K Buy
13,900
+3,000
+28% +$5.8K ﹤0.01% 1257
2015
Q3 		$21K Hold
10,900
– – ﹤0.01% 1328
2015
Q2 		$30K Buy
+10,900
New +$30K ﹤0.01% 1453

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer & Co's APYX Position: Q3 2016 in Review

Oppenheimer & Co sold out of Apyx Medical (APYX) in Q3 2016, closing a stake of 10,400 shares — an estimated $17K sold.

Oppenheimer & Co first reported a position in APYX in Q2 2015 and held it in 5 quarters. The position peaked at $30K in Q2 2015. 37 funds tracked by Wall St. Rank hold APYX as of Q3 2016.

  • Oppenheimer & Co reported no remaining Apyx Medical position as of Q3 2016 after selling out during the quarter.
  • Oppenheimer & Co sold 10,400 Apyx Medical shares in Q3 2016, an estimated $17K.
  • Oppenheimer & Co first reported a position in Apyx Medical in Q2 2015 and held it in 5 quarters.
  • Oppenheimer & Co's Apyx Medical position peaked at $30K in Q2 2015.
  • 37 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2016.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.